Thang H. Nguyen

Array ( [id] => 10974232 [patent_doc_number] => 20140377267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-25 [patent_title] => 'ANTIBODIES TO CROSS-LINKED AMYLOID BETA OLIGOMERS' [patent_app_type] => utility [patent_app_number] => 14/453007 [patent_app_country] => US [patent_app_date] => 2014-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13904 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14453007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10974232 [patent_doc_number] => 20140377267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-25 [patent_title] => 'ANTIBODIES TO CROSS-LINKED AMYLOID BETA OLIGOMERS' [patent_app_type] => utility [patent_app_number] => 14/453007 [patent_app_country] => US [patent_app_date] => 2014-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13904 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14453007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12212139 [patent_doc_number] => 09908933 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-06 [patent_title] => 'Antibody therapy for amyloid beta disease' [patent_app_type] => utility [patent_app_number] => 14/910172 [patent_app_country] => US [patent_app_date] => 2014-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16355 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14910172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9812006 [patent_doc_number] => 20150023952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-22 [patent_title] => 'ANTI-ADDL MONOCLONAL ANTIBODY AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/326974 [patent_app_country] => US [patent_app_date] => 2014-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 18987 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14326974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10815321 [patent_doc_number] => 20160161481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-09 [patent_title] => 'METHOD FOR DETECTING INDICATORS FOR DETERMINING DISEASES' [patent_app_type] => utility [patent_app_number] => 14/900361 [patent_app_country] => US [patent_app_date] => 2014-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 26703 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14900361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11090703 [patent_doc_number] => 20160287671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-06 [patent_title] => 'BOOSTING TREG CELLS FOR TREATING ALZHEIMER DISEASE AND RELATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/392315 [patent_app_country] => US [patent_app_date] => 2014-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12421 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14392315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10381968 [patent_doc_number] => 20150266975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-24 [patent_title] => 'RNA-SPECIFIC BINDING ANTIBODY' [patent_app_type] => utility [patent_app_number] => 14/302559 [patent_app_country] => US [patent_app_date] => 2014-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 10215 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14302559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9916710 [patent_doc_number] => 20150071915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-12 [patent_title] => 'MONOCLONAL ANTIBODIES AGAINST AMYLOID BETA PROTEIN AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/303300 [patent_app_country] => US [patent_app_date] => 2014-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 28430 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14303300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10777840 [patent_doc_number] => 20160123997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-05 [patent_title] => 'MATERIALS AND METHODS RELATING TO ALZHEIMER\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 14/896388 [patent_app_country] => US [patent_app_date] => 2014-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8798 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14896388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10945859 [patent_doc_number] => 20140348881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-27 [patent_title] => 'METHOD FOR DIAGNOSING AND TREATING DYSAUTONOMIA AND OTHER DYSAUTONOMIC CONDITIONS' [patent_app_type] => utility [patent_app_number] => 14/296091 [patent_app_country] => US [patent_app_date] => 2014-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4365 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14296091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9756262 [patent_doc_number] => 20140286963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'METHODS AND COMPOSITIONS FOR NEURAL DISEASE IMMUNOTHERAPY' [patent_app_type] => utility [patent_app_number] => 14/292461 [patent_app_country] => US [patent_app_date] => 2014-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 42255 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14292461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10755988 [patent_doc_number] => 20160102140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-14 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING BRAIN DISEASES' [patent_app_type] => utility [patent_app_number] => 14/894285 [patent_app_country] => US [patent_app_date] => 2014-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14571 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14894285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9719715 [patent_doc_number] => 20140255414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-11 [patent_title] => 'DIAGNOSTIC ANTIBODY ASSAY' [patent_app_type] => utility [patent_app_number] => 14/280919 [patent_app_country] => US [patent_app_date] => 2014-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 30480 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14280919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11663586 [patent_doc_number] => 20170152306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-01 [patent_title] => 'SINGLE CHAIN VARIABLE FRAGMENT (SCFV) ELONGATION MUTANTS' [patent_app_type] => utility [patent_app_number] => 15/311478 [patent_app_country] => US [patent_app_date] => 2014-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 14232 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15311478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10721159 [patent_doc_number] => 20160067306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-10 [patent_title] => 'TREATMENT AGENT FOR COGNITIVE IMPAIRMENT INDUCED BY AMYLOID BETA-PROTEIN, THERAPEUTIC AGENT FOR ALZHEIMER\'S DISEASE, AND TREATMENT METHOD AND PATHOLOGICAL ANALYSIS METHOD RELATED TO THESE' [patent_app_type] => utility [patent_app_number] => 14/785204 [patent_app_country] => US [patent_app_date] => 2014-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8691 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14785204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9634373 [patent_doc_number] => 20140212481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-31 [patent_title] => 'IMMUNOLOGICAL METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALZHEIMER\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 14/246830 [patent_app_country] => US [patent_app_date] => 2014-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19604 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14246830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9756254 [patent_doc_number] => 20140286956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'MODULATING INFLAMMASOME ACTIVITY AND INFLAMMATION IN THE CENTRAL NERVOUS SYSTEM' [patent_app_type] => utility [patent_app_number] => 14/219857 [patent_app_country] => US [patent_app_date] => 2014-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16113 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14219857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11698844 [patent_doc_number] => 09688747 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-27 [patent_title] => 'Methods and compositions for the generation and use of conformation-specific antibodies' [patent_app_type] => utility [patent_app_number] => 14/776924 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 18424 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13013919 [patent_doc_number] => 10030067 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-24 [patent_title] => Compounds for treating neurodegenerative proteinopathies [patent_app_type] => utility [patent_app_number] => 14/775302 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 48 [patent_no_of_words] => 16778 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14775302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9634325 [patent_doc_number] => 20140212433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-31 [patent_title] => 'Humanized Anti-Factor D Antibodies And Uses Thereof' [patent_app_type] => utility [patent_app_number] => 14/198021 [patent_app_country] => US [patent_app_date] => 2014-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 41978 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14198021 [rel_patent_id] =>[rel_patent_doc_number] =>)